Compass Therapeutics (CMPX) said Tuesday it appointed Barry Shin as chief financial officer, effective Dec. 9.
Shin previously worked as executive vice president, chief operating officer and chief financial officer at Trevena (TRVN), the company said.
Compass Therapeutics' shares were up 5.5% in recent trading.
Price: 1.74, Change: +0.09, Percent Change: +5.45